Beam Therapeutics' CEO Sold Over 30,000 Company Shares. Here's What This Means for Investors.

CEO John Evans sold 30,078 company shares for a transaction value of ~$739,000 on April 1, 2026. The sale represented 2.5% of his direct holdings.